OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Sapna Thakur, Sonu Gupta, Villayat Ali, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 7, pp. 655-667
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107221-107221
Closed Access | Times Cited: 51

Recent advances in the treatment and delivery system of diabetic retinopathy
Zhiyi Wang, Ningzhi Zhang, Pei Lin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 19

Physiological and Pathological Roles of Aldose Reductase
Mahavir Singh, Aniruddh Kapoor, Aruni Bhatnagar
Metabolites (2021) Vol. 11, Iss. 10, pp. 655-655
Open Access | Times Cited: 97

Stimuli-responsive therapeutic systems for the treatment of diabetic infected wounds
Yanling Hu, Hui Li, Xinyi Lv, et al.
Nanoscale (2022) Vol. 14, Iss. 36, pp. 12967-12983
Closed Access | Times Cited: 65

Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Pharmacological Research (2022) Vol. 183, pp. 106367-106367
Closed Access | Times Cited: 56

The Good, the Bad and the New about Uric Acid in Cancer
S. Allegrini, Mercedes Garcia‐Gil, Rossana Pesi, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4959-4959
Open Access | Times Cited: 44

Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury
Minzhen Deng, Jingbo Sun, Lilin Peng, et al.
Phytomedicine (2022) Vol. 103, pp. 154214-154214
Open Access | Times Cited: 43

Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment
Qingxia Lin, Kezheng Li, Yinuo Chen, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4574-4594
Closed Access | Times Cited: 38

How inflammation dictates diabetic peripheral neuropathy: An enlightening review
Yifan Cheng, Yinuo Chen, Kezheng Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 26

Associations of genetic factors with vascular diabetes complications: an umbrella review
Xuan Zhou, Nan Yang, Wei Xu, et al.
Journal of Global Health (2025) Vol. 15
Open Access | Times Cited: 1

N‐substituted phthalazine sulfonamide derivatives as non‐classical aldose reductase inhibitors
Cüneyt Türkeş, Mustafa Arslan, Yeliz Demir, et al.
Journal of Molecular Recognition (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 34

Design, synthesis, and aldose reductase inhibitory effect of some novel carboxylic acid derivatives bearing 2-substituted-6-aryloxo-pyridazinone moiety
Mevlüt Akdağ, Azime Berna Özçelik, Yeliz Demir, et al.
Journal of Molecular Structure (2022) Vol. 1258, pp. 132675-132675
Closed Access | Times Cited: 33

Exploration of Some Bis‐Sulfide and Bis‐Sulfone Derivatives as Non‐Classical Aldose Reductase İnhibitors
Cüneyt Türkeş, Yeliz Demir, Abdullah Biçer, et al.
ChemistrySelect (2023) Vol. 8, Iss. 5
Closed Access | Times Cited: 19

Aldose reductase with quinolone antibiotics interaction: In vitro and in silico approach of its relationship with diabetic complications
Cüneyt Türkeş
Archives of Biochemistry and Biophysics (2024), pp. 110161-110161
Closed Access | Times Cited: 7

In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**
Cüneyt Türkeş, Yeliz Demir, Şükrü Beydemir
ChemistrySelect (2022) Vol. 7, Iss. 48
Open Access | Times Cited: 25

Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
European Journal of Pharmacology (2022) Vol. 931, pp. 175191-175191
Closed Access | Times Cited: 23

Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract
Zaoxia Guo, Xiao‐Pan Ma, Ruixue Zhang, et al.
Advances in Ophthalmology Practice and Research (2023) Vol. 3, Iss. 4, pp. 180-186
Open Access | Times Cited: 16

Insights into the liver-eyes connections, from epidemiological, mechanical studies to clinical translation
Junhao Wu, Caihan Duan, Yuanfan Yang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14

Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi
Xiaoqi Sun, Ying Shi, Dongxiao Shi, et al.
Journal of Fungi (2024) Vol. 10, Iss. 2, pp. 144-144
Open Access | Times Cited: 6

Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy
Yulian Liu, Runyuan Yu, Xiaoyu Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116350-116350
Open Access | Times Cited: 5

Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-a]pyridine Derivatives
Betül Kaya, Ulviye Acar Çevik, Bilge Çiftçi, et al.
ACS Omega (2024) Vol. 9, Iss. 42, pp. 42905-42914
Closed Access | Times Cited: 5

An update on nutritional profile, phytochemical compounds, health benefits, and potential applications in the food industry of pulses seed coats: A comprehensive review
Dianzhi Hou, Qiqian Feng, Jian Tang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 14, pp. 1960-1982
Closed Access | Times Cited: 20

Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy
Manni Rohilla, Rishabh, Seema Bansal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115881-115881
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top